Immunohistochemical Evidence for Myofibroblast-like Cells Associated with Liver Injury Induced by Aflatoxin B1 in Rainbow Trout (Oncorhynchus mykiss)

Carregando...
Imagem de Miniatura
Citações na Scopus
16
Tipo de produção
article
Data de publicação
2014
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCI LTD
Autores
ARANA, S.
SABINO, M.
TABATA, Y. A.
NONOGAKI, S.
ZAIDAN-DAGLI, M. -L.
HERNANDEZ-BAZQUEZ, F. J.
Citação
JOURNAL OF COMPARATIVE PATHOLOGY, v.150, n.2-3, p.258-265, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
In mammalian species, profibrogenic cells are activated to become myofibroblasts in response to liver damage. Few studies have examined hepatic myofibroblasts and their role in liver damage in teleosts. The aim of the present study was to investigate the involvement of myofibroblast-like cells in rainbow trout (Oncorhynchus mykiss) with hepatic damage induced by aflatoxin B1 (AFB1). Histopathological and immunohistochemical analyses characterized alterations in the liver stroma during the carcinogenic process. Anti-human a-smooth muscle actin (SMA) and anti-human desmin primary antibodies were used in immunohistochemistry. Only the anti-SMA reagent labelled cells in. trout liver. In the livers of control fish, only smooth muscle in blood vessels and around bile ducts was labelled. In the livers from AFB1-treated fish, SMA-positive cells were present in the stroma surrounding neoplastic lesions and in areas of desmoplastic reaction. These observations indicate that in teleosts, as in mammals, the myofibroblast-like cell is involved in fibrosis associated with liver injury. Chronic liver injury induced in trout by aflatoxin may provide a useful model system for study of the evolution of such mechanisms.
Palavras-chave
fish, hepatocarcinogenesis, liver fibrosis, myofibroblast
Referências
  1. Ahmad A, 2012, SAUDI J GASTROENTERO, V18, P155, DOI 10.4103/1319-3767.96445
  2. Arana S, 2011, PESQUISA VET BRASIL, V31, P751, DOI 10.1590/S0100-736X2011000900005
  3. Arana S, 2002, ARCH MED VET, V34, P253, DOI 10.4067/S0301-732X2002000200011
  4. Bailey GS, 1996, ENVIRON HEALTH PERSP, V104, P5, DOI 10.2307/3432693
  5. Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
  6. Benyon RC, 2000, GUT, V46, P443, DOI 10.1136/gut.46.4.443
  7. Bioulac-Sage P, 2000, GASTROEN CLIN BIOL, V24, P877
  8. BUNTON TE, 1995, CARCINOGENESIS, V16, P1059, DOI 10.1093/carcin/16.5.1059
  9. Choi SS, 2009, AM J PHYSIOL-GASTR L, V297, pG1093, DOI 10.1152/ajpgi.00292.2009
  10. COUCH JA, 1987, J NATL CANCER I, V79, P297
  11. COUCH JA, 1991, TOXICOL PATHOL, V19, P237
  12. Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
  13. Hendricks J D, 1984, Natl Cancer Inst Monogr, V65, P321
  14. HENDRICKS JD, 1995, TOXICOL PATHOL, V23, P447
  15. Hinton David E., 1998, EXS, V86, P141
  16. Hobbie KR, 2012, VET PATHOL, V49, P372, DOI 10.1177/0300985811409443
  17. Iwaisako K, 2012, J GASTROEN HEPATOL, V27, P65, DOI 10.1111/j.1440-1746.2011.07002.x
  18. Li CY, 2009, J HEPATOL, V50, P1174, DOI 10.1016/j.jhep.2009.01.028
  19. Lu JW, 2011, BIRTH DEFECTS RES C, V93, P157, DOI 10.1002/bdrc.20205
  20. Makovicky P, 2011, PATHOL RES PRACT, V207, P151, DOI 10.1016/j.prp.2010.12.002
  21. Neaud V, 1997, HEPATOLOGY, V26, P1458, DOI 10.1002/hep.510260612
  22. Neaud V, 2000, J BIOL CHEM, V275, P35565, DOI 10.1074/jbc.M006101200
  23. Ochiai K., 2003, Avian Pathology, V32, P425
  24. Okihiro MS, 1999, CARCINOGENESIS, V20, P933, DOI 10.1093/carcin/20.6.933
  25. Okihiro MS, 2000, TOXICOL PATHOL, V28, P342, DOI 10.1177/019262330002800215
  26. Otranto M, 2012, CELL ADHES MIGR, V6, P203, DOI 10.4161/cam.20377
  27. Parola M, 2008, MOL ASPECTS MED, V29, P58, DOI 10.1016/j.mam.2007.09.002
  28. Rahimi RS, 2012, CURR OPIN GASTROEN, V28, P223, DOI 10.1097/MOG.0b013e328351d003
  29. Rekha RD, 2008, TOXICOLOGY, V243, P11, DOI 10.1016/j.tox.2007.09.007
  30. SCHMITTGRAFF A, 1991, AM J PATHOL, V138, P1233
  31. Senda T, 2003, ARCH HISTOL CYTOL, V66, P437, DOI 10.1679/aohc.66.437
  32. SOARES LMV, 1989, J ASSOC OFF ANA CHEM, V72, P22
  33. Starkel P, 2011, BEST PRACT RES CL GA, V25, P319, DOI 10.1016/j.bpg.2011.02.004
  34. Tilton SC, 2005, TOXICOL SCI, V88, P319, DOI 10.1093/toxsci/kfi309
  35. Van Wettere AJ, 2013, TOXICOL PATHOL, V41, P744, DOI 10.1177/0192623312464308
  36. Williams David E., 2003, Toxicologic Pathology, V31, P58, DOI 10.1080/01926230390174940
  37. Williams DE, 2012, COMP BIOCHEM PHYS C, V155, P121, DOI 10.1016/j.cbpc.2011.05.013
  38. Wolf JC, 2005, TOXICOL PATHOL, V33, P75, DOI 10.1080/01926230590890187
  39. Yamamoto H, 1997, GASTROENTEROLOGY, V112, P1290, DOI 10.1016/S0016-5085(97)70143-4
  40. YAMAMOTO K, 1986, HEPATOLOGY, V6, P54, DOI 10.1002/hep.1840060111
  41. YOKOI Y, 1984, HEPATOLOGY, V4, P709, DOI 10.1002/hep.1840040425
  42. Zhao LN, 2007, J MOL HISTOL, V38, P53, DOI 10.1007/s10735-007-9078-5